{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T12:43:31Z","timestamp":1777034611367,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.jaad.2010.10.020","type":"journal-article","created":{"date-parts":[[2011,5,28]],"date-time":"2011-05-28T06:05:48Z","timestamp":1306562748000},"page":"e67-e76","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis"],"prefix":"10.1016","volume":"66","author":[{"given":"Alexa Boer","family":"Kimball","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Signorovitch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jipan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Magda","family":"Tsaneva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiraz R.","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjun","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parvez M.","family":"Mulani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2010.10.020_bib1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jaad.2008.09.022","article-title":"The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004","volume":"60","author":"Kurd","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib2","first-page":"1","article-title":"Current estimates from the national health interview survey, 1996","volume":"200","author":"Adams","year":"1999","journal-title":"Vital Health Stat 10"},{"key":"10.1016\/j.jaad.2010.10.020_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199503023320907","article-title":"Treatment of psoriasis","volume":"332","author":"Greaves","year":"1995","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.jaad.2010.10.020_bib4","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2165\/00128071-200506060-00005","article-title":"The psychosocial burden of psoriasis","volume":"6","author":"Kimball","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib5","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.jaad.2008.02.039","article-title":"Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics","volume":"58","author":"Menter","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib6","unstructured":"The Society for Investigative Dermatology and the American Academy of Dermatology Association. The burden of skin diseases 2004. Available from: URL:http:\/\/www.sidnet.org\/pdfs\/Burden%20of%20Skin%20Diseases%202004.pdf. Accessed April 13, 2009."},{"key":"10.1016\/j.jaad.2010.10.020_bib7","unstructured":"National Psoriasis Foundation. Benchmark survey on psoriasis and psoriatic arthritis: summary of top line results. Available from: URL:http:\/\/www.psoriasis.org\/files\/pdfs\/press\/npfsurvey.pdf. Accessed April 13, 2009."},{"key":"10.1016\/j.jaad.2010.10.020_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000093848","article-title":"Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis","volume":"213","author":"Schmitt","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2010.10.020_bib9","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1080\/09546630500482886","article-title":"The negative impact of psoriasis on the workplace","volume":"17","author":"Pearce","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2010.10.020_bib10","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.jaad.2008.06.043","article-title":"The impact of psoriasis on health care costs and patient work loss","volume":"59","author":"Fowler","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib11","first-page":"381","article-title":"Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis","volume":"17","author":"Reich","year":"2007","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jaad.2010.10.020_bib13","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2165\/00019053-200422040-00002","article-title":"A review of self-report instruments measuring health-related work productivity: a patient-reported outcomes perspective","volume":"22","author":"Prasad","year":"2004","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.jaad.2010.10.020_bib14","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1067\/mjd.2003.128","article-title":"Validation of the Dermatology Life Quality Index and the Work Productivity and\u00a0Activity Impairment-Chronic Hand Dermatitis questionnaire in chronic hand dermatitis","volume":"48","author":"Reilly","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib15","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/rheumatology\/kep457","article-title":"Validity, reliability and responsiveness of the Work Productivity and Activity Impairment Questionnaire in ankylosing spondylitis","volume":"49","author":"Reilly","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jaad.2010.10.020_bib16","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.clinthera.2008.02.016","article-title":"Validity, reliability, and responsiveness of the work productivity and activity impairment questionnaire in Crohn's disease","volume":"30","author":"Reilly","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2010.10.020_bib17","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2036.2004.02091.x","article-title":"The validity and accuracy of the Work Productivity and Activity Impairment Questionnaire-Irritable Bowel Syndrome version (WPAI: IBS)","volume":"20","author":"Reilly","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jaad.2010.10.020_bib18","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1468-3083.2010.03600.x","article-title":"Psoriasis: an epidemiological evaluation of disease burden in 590 patients","volume":"24","author":"Meyer","year":"2010","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.020_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2165\/11310440-000000000-00000","article-title":"Impact of psoriasis on patients' work and productivity: a retrospective, matched case-control analysis","volume":"10","author":"Wu","year":"2009","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib20","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2310\/7750.2009.08068","article-title":"Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasis","volume":"13","author":"Chan","year":"2009","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2010.10.020_bib21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1080\/09546630701646172","article-title":"Impact of adalimumab treatment on patient-reported outcomes: results from a phase III clinical trial in patients with moderate to severe plaque psoriasis","volume":"18","author":"Revicki","year":"2007","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2010.10.020_bib22","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/j.1365-2133.2007.08236.x","article-title":"Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis","volume":"158","author":"Revicki","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib23","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.jaad.2007.09.010","article-title":"Adalimumab therapy for moderate to severe psoriasis: a randomized, controlled phase III trial","volume":"58","author":"Menter","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib24","unstructured":"Reilly Associates. WPAI scoring. Available from: URL:http:\/\/www.reillyassociates.net\/WPAI_Scoring.html. Accessed April 27, 2009."},{"key":"10.1016\/j.jaad.2010.10.020_bib25","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis: oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2010.10.020_bib26","unstructured":"The European Medicines Agency. Guideline on clinical investigation of medicinal products indicated for the treatment of psoriasis, 2004. Available from: URL:http:\/\/www.emea.europa.eu\/pdfs\/human\/ewp\/245402en.pdf. Accessed December 11, 2009."},{"key":"10.1016\/j.jaad.2010.10.020_bib27","unstructured":"Ko H-S. Clinical trial design in psoriasis. Presented at: 49th Meeting of the Dermatologic and Ophthalmologic Advisory Committee; March 20, 1998; Bethesda, MD."},{"key":"10.1016\/j.jaad.2010.10.020_bib28","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1365-2230.1994.tb01167.x","article-title":"Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use","volume":"19","author":"Finlay","year":"1994","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib29","first-page":"997","article-title":"The Dermatology Life Quality Index 1994\u20132007: a comprehensive review of validation data and clinical results","volume":"159","author":"Basra","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib30","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","article-title":"Translating the science of quality of life into practice: what do Dermatology Life Quality Index scores mean?","volume":"125","author":"Hongbo","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib31","unstructured":"National Institute for Health and Clinical Excellence. Adalimumab for the treatment of adults with psoriasis. Available from: URL:http:\/\/www.nice.org.uk\/nicemedia\/pdf\/TA146Guidance.pdf. Accessed November 13, 2009."},{"key":"10.1016\/j.jaad.2010.10.020_bib32","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1365-2133.2009.09491.x","article-title":"Ustekinumab improves health-related quality of life in patients with moderate-to-severe psoriasis: results from the PHOENIX 1 trial","volume":"162","author":"Lebwohl","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib33","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jaad.2009.04.053","article-title":"Randomized, double-blind, placebo-controlled evaluation of the efficacy of oral psoralen plus ultraviolet A\u00a0for the treatment of plaque-type psoriasis using the Psoriasis Area Severity Index score (improvement of 75% or greater) at 12 weeks","volume":"61","author":"Sivanesan","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib34","first-page":"1177","article-title":"Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension","volume":"159","author":"van de Kerkhof","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib35","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1365-2133.2007.08315.x","article-title":"Efficacy and safety results from the randomized controlled comparative study of adalimumab vs methotrexate vs placebo in patients with psoriasis (CHAMPION)","volume":"158","author":"Saurat","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.020_bib36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/01.MLR.0000062554.74615.4C","article-title":"Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation","volume":"41","author":"Norman","year":"2003","journal-title":"Med Care"},{"key":"10.1016\/j.jaad.2010.10.020_bib37","unstructured":"US Department of Labor, Bureau of Labor Statistics. National occupational employment and wage estimates. 2007. Available from: URL:http:\/\/www.bls.gov\/oes\/current\/oes_nat.htm#b00-0000. Accessed April 13, 2009."},{"key":"10.1016\/j.jaad.2010.10.020_bib38","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.jaad.2007.07.023","article-title":"Association of patient-reported psoriasis severity with income and employment","volume":"57","author":"Horn","year":"2007","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962210020049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962210020049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:23:00Z","timestamp":1759270980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962210020049"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0190962210020049"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2010.10.020","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2010.10.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}